$XBI, the SPDR S&P Biotech ETF, generated 63 mentions across 12 months from five distinct FinTwit voices, with @alphaticaio (Alphatica) accounting for 57 of those mentions. The first mention appeared on March 20, 2026, while the most recent post occurred on July 15, 2026. The dominant voice category was long research, with @alphaticaio providing sustained technical and thematic rotation analysis throughout the period.

@alphaticaio's coverage centered on $XBI's performance within a broader rotation scanner framework tracking biotech alongside other thematic ETFs like $SOXX, $ARKK, and $TAN. On July 10, 2026, @alphaticaio noted $XBI declined 3.6% as biotech crashed alongside all four thematics turning negative. By July 13, $XBI fell 2.1% amid defensive positioning ahead of CPI data, while July 15 showed $XBI posting a modest +0.3% gain as volatility settled into week three of Q3. The remaining voices—@adamfeuerstein, @acinvestorblog, @alfcharts, and @yasutaketin—each contributed single mentions without establishing sustained thematic discussion.